14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

$0.0536
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Nov 24, 2017 $0.195 $0.200 $0.187 $0.195 1 342 126
Nov 22, 2017 $0.203 $0.207 $0.192 $0.195 2 904 611
Nov 21, 2017 $0.202 $0.209 $0.195 $0.203 2 470 800
Nov 20, 2017 $0.205 $0.212 $0.182 $0.200 4 735 900
Nov 17, 2017 $0.209 $0.209 $0.195 $0.199 3 986 500
Nov 16, 2017 $0.190 $0.210 $0.181 $0.205 10 031 700
Nov 15, 2017 $3.68 $3.76 $3.30 $3.57 359 164
Nov 14, 2017 $4.30 $4.32 $3.44 $3.64 741 606
Nov 13, 2017 $5.04 $5.80 $4.10 $4.36 699 983
Nov 10, 2017 $3.56 $3.58 $3.20 $3.48 217 981
Nov 09, 2017 $3.40 $4.00 $3.24 $3.70 678 640
Nov 08, 2017 $3.00 $3.48 $3.00 $3.16 434 750
Nov 07, 2017 $3.40 $3.44 $2.96 $3.00 267 276
Nov 06, 2017 $2.80 $3.30 $2.80 $3.28 163 921
Nov 03, 2017 $2.64 $2.90 $2.64 $2.84 59 730
Nov 02, 2017 $2.86 $2.92 $2.62 $2.80 82 631
Nov 01, 2017 $3.00 $3.04 $2.84 $2.91 49 112
Oct 31, 2017 $3.00 $3.00 $2.80 $3.00 42 528
Oct 30, 2017 $3.00 $3.10 $2.92 $2.98 87 743
Oct 27, 2017 $3.28 $3.28 $3.00 $3.17 156 137
Oct 26, 2017 $3.36 $3.36 $3.22 $3.23 115 201
Oct 25, 2017 $3.26 $3.38 $3.26 $3.35 93 163
Oct 24, 2017 $3.38 $3.40 $3.26 $3.30 89 336
Oct 23, 2017 $3.40 $3.42 $3.30 $3.39 72 342
Oct 20, 2017 $3.40 $3.46 $3.28 $3.35 97 222
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT